In contrast, during days 1–7 post-eradication, the 3B-R group showed a trend toward an increased incidence of diarrhea compared to the placebo group, although no significant difference in the degree of α-diversity decline was observed between patients with and without diarrhea during this early phase (Fig.
← all excerpts
Impact of Enterococcus faecium 129 BIO 3B-R on Helicobacter pylori eradication therapy side effects in adult patients: a randomized, double-blind, placebo-controlled study.
1
—
—